In focus · trending topic

OncoMed

11 stories · following the connections

OncoMed Doses First Patient with GITRL-Fc in Phase 1a Clinical Trial

By Nasdaq OMXSep 13, 2017, 12:05 PM UTC

OncoMed Pharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial Results

By Nasdaq OMXMar 8, 2017, 9:06 PM UTC

OncoMed Pharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial Results

By Nasdaq OMXMar 8, 2017, 9:06 PM UTC

OncoMed Announces Year-End Cash Balance and 2017 Outlook

By Nasdaq OMXJan 5, 2017, 1:31 PM UTC

OncoMed Announces Year-End Cash Balance and 2017 Outlook

By Nasdaq OMXJan 5, 2017, 1:31 PM UTC

OncoMed Pharmaceuticals Reports Third Quarter 2016 Financial Results

By Nasdaq OMXNov 1, 2016, 8:06 PM UTC

OncoMed Pharmaceuticals Completes Enrollment of Phase 2 YOSEMITE Clinical Trial of Demcizumab in Pancreatic Cancer

By Nasdaq OMXSep 1, 2016, 12:01 PM UTC

OncoMed Pharmaceuticals Completes Enrollment of Phase 2 PINNACLE Clinical Trial of Tarextumab in Small Cell Lung Cancer

By Nasdaq OMXAug 30, 2016, 12:00 PM UTC